Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (151-160 of 361) with videos related to

Pageof 37
Sort By:
American Journal of Medical Genetics. Part A|May 13, 2025
Parental Communication with their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and CounselingMarcelo M Sleiman, Talia Zamir, Beth N Peshkin, et al.
Future Oncology (London, England)|October 15, 2016
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationaleSteven J Isakoff, Shannon Puhalla, Susan M Domchek, et al.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
Cancer Cell|June 14, 2022
Cancer vaccinesJohn T Schiller, Douglas R Lowy, Ian H Frazer, et al.
Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 19, 2024
Prevalence of H. pylori and Gastric Intestinal Metaplasia in BRCA1 and BRCA2 CarriersBlake A Niccum, Sarah Coughlin, Daniel Clay, et al.
Radiology|July 21, 2007
Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening studyConstance D Lehman, Claudine Isaacs, Mitchell D Schnall, et al.
JCI Insight|April 28, 2026
Comparative analysis of distinct genomic landscapes in young-onset gBRCA1/2 breast cancerMwangala P Akamandisa, Mingyi Xia, Wilson Cheah, et al.
Pageof 37

Showing results (151-160 of 361) with videos related to

Sort By:
Pageof 37
American Journal of Medical Genetics. Part A|May 13, 2025
Parental Communication with their Children about Cancer Risk and DTC Cascade Genetic Testing: Implications for Genetic Education and CounselingMarcelo M Sleiman, Talia Zamir, Beth N Peshkin, et al.
Future Oncology (London, England)|October 15, 2016
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationaleSteven J Isakoff, Shannon Puhalla, Susan M Domchek, et al.
JCO Precision Oncology|July 29, 2021
Comprehensive Breast Cancer Risk Assessment for <i>CHEK2</i> and <i>ATM</i> Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick ModelShannon Gallagher, Elisha Hughes, Allison W Kurian, et al.
Breast Cancer Research and Treatment|April 23, 2010
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomyLori J Pierce, Kelly-Anne Phillips, Kent A Griffith, et al.
Cancer Cell|June 14, 2022
Cancer vaccinesJohn T Schiller, Douglas R Lowy, Ian H Frazer, et al.
Gynecologic Oncology|January 3, 2016
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapySusan M Domchek, Carol Aghajanian, Ronnie Shapira-Frommer, et al.
JCO Precision Oncology|February 26, 2020
Returning Individual Genetic Research Results to Research Participants: Uptake and Outcomes Among Patients With Breast CancerAngela R Bradbury, Linda Patrick-Miller, Brian L Egleston, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 19, 2024
Prevalence of H. pylori and Gastric Intestinal Metaplasia in BRCA1 and BRCA2 CarriersBlake A Niccum, Sarah Coughlin, Daniel Clay, et al.
Radiology|July 21, 2007
Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening studyConstance D Lehman, Claudine Isaacs, Mitchell D Schnall, et al.
JCI Insight|April 28, 2026
Comparative analysis of distinct genomic landscapes in young-onset gBRCA1/2 breast cancerMwangala P Akamandisa, Mingyi Xia, Wilson Cheah, et al.
Pageof 37